Please assess the completion status of the following clinical trial:

Trial Title: Mesenchymal Stem Cells in Knee Cartilage Injuries

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* MRI must show moderate/severe articular injury~* Serum collagen II must be above the normal value.~* Lesion site: Femoral and Tibial condyles or patella~* Admission of steroid , NSAID, pain killers must be stopped before 1 month~Exclusion Criteria:~* Lesion size~* PT and PTT not within normal value~* Complete blood count ( Hb, PCV, and RBC) not within the normal value~* HIV and Hepatitis Antigens (B and C) detection

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 68 Years
- Healthy Volunteers: f

Study Arms:
- mesenchymal stem cells (Type: ACTIVE_COMPARATOR): Autologous Mesenchymal Stem Cells primed prior to intra articular injection into knees of patients with advanced articular cartilage injury
- mesenchymal cells&platelet lysate (Type: ACTIVE_COMPARATOR): Autologous Mesenchymal Stem Cells primed prior to intra articular injection with platelet lysate into knees of patients with advanced articular cartilage injury

Based on this trial design, predict the completion outcome and termination type (if applicable).